Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-9
pubmed:abstractText
Since direct injection of naked mRNA induces an immune response, we tested the capacity of RNA to signal danger. We show here that mRNA molecules that are protected from immediate degradation either through interaction with cationic proteins (trans protection) or through chemical modification of the phosphodiester backbone (phosphorothioate RNA; cis protection) act as sequence-independent danger signals on mouse DC. As opposed to CpG DNA, the cis-stabilized RNA is degraded in a few minutes, does not activate B cells and, in contrast to double-stranded RNA, requires MyD88 for activation of the DC. We postulate that phosphorothioate RNA, which mimics trans-stabilized RNA, is a new PAMP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing, http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/Myd88 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Myeloid Differentiation Factor 88, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Thionucleotides
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0014-2980
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
537-47
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14768059-Adaptor Proteins, Signal Transducing, pubmed-meshheading:14768059-Adjuvants, Immunologic, pubmed-meshheading:14768059-Animals, pubmed-meshheading:14768059-Antigens, CD, pubmed-meshheading:14768059-Antigens, Differentiation, pubmed-meshheading:14768059-Dendritic Cells, pubmed-meshheading:14768059-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:14768059-Immunization, pubmed-meshheading:14768059-Interleukin-12, pubmed-meshheading:14768059-Interleukin-6, pubmed-meshheading:14768059-Lymphocyte Activation, pubmed-meshheading:14768059-Mice, pubmed-meshheading:14768059-Mice, Inbred BALB C, pubmed-meshheading:14768059-Mice, Inbred C57BL, pubmed-meshheading:14768059-Mice, Knockout, pubmed-meshheading:14768059-Myeloid Differentiation Factor 88, pubmed-meshheading:14768059-RNA, Messenger, pubmed-meshheading:14768059-Receptors, Immunologic, pubmed-meshheading:14768059-Spleen, pubmed-meshheading:14768059-Thionucleotides
pubmed:year
2004
pubmed:articleTitle
Immunostimulating capacities of stabilized RNA molecules.
pubmed:affiliation
CureVac GmbH, Tübingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't